U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198932) titled 'Cofrogliptin and Linagliptin as add-on Therapy to Insulin in Type 2 Diabetes' on Sept. 19.
Brief Summary: This study is a multicenter, prospective, non-interventional real-world study to evaluate the clinical outcomes of biweekly cofrogliptin versus daily linagliptin as an add-on therapy in Chinese adult T2D patients.
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: Cofrogliptin add to insulin
Patients will be treated with commercially available cofrogliptin according to routine clinical practice at the discretion of the treating physician.
DRUG: Linagliptin add to insulin
Pa...